90/019,240Occlusion Device11,284,901Closed

Status

Reexamination Certificate Issued

Filed

Aug 24, 2023

Last Updated

Aug 21, 2024

Art Unit

3993

Requester

Unknown

Requester Law Firm

Unknown

Requested By

Third Party

Patent OwnerInferred

Cerus Endovascular Limited

P.O. Law Firm

MbHb

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61BDiagnosis & Surgery

USPC

606Surgery

Reexam History (33 events)

Aug 21, 2024REEXInput Issue Number and Issue Date for Reexamination
Aug 6, 2024RXPUBSReexam Forwarded to Office of Publications
Aug 1, 2024ELC_RVWElectronic Review
Jul 31, 2024MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
May 28, 2024RXC/SRCertificate of Service
May 28, 2024RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
May 28, 2024RXA...Response after Non-Final Action
May 20, 2024RXLET.Miscellaneous Incoming Letter
May 20, 2024RXC/SRCertificate of Service
Apr 26, 2024MREXNRX - Mail Examiner Interview Summary Record
Apr 24, 2024MRXG.RX - Mail Extension of Time Period for Response Granted
Apr 22, 2024RXRQ/TRequest for Extension of Time
Apr 22, 2024RXC/SRCertificate of Service
Feb 27, 2024MR.NFRX - Mail Reexam Non-Final Action
Dec 12, 2023RXFWDXDate Forwarded to Examiner
Sep 25, 2023MREXORX - Mail Ex Parte Request for Reexamination Granted
Sep 7, 2023MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Aug 30, 2023RXLITSRReexam Litigation Search Conducted
Aug 30, 2023MRXNReexamination Formalities Notice Mailed
Aug 30, 2023MRXNReexamination Formalities Notice Mailed
Aug 30, 2023DOCKCase Docketed to Examiner in GAU
Aug 29, 2023RXTTLRPTTitle Report
Aug 29, 2023RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Aug 29, 2023FTFSFITF set to YES - revise initial setting
Aug 28, 2023RXNREQFDNotice of reexamination request filing date
Aug 28, 2023RXNREQAUNotice of assignment of reexamination request
Aug 25, 2023PRXRParalegal Reexam Review Complete
Aug 24, 2023RXOSUB.RReexamination requested by third party requester
Aug 24, 2023RXOSUBReceipt of Original Ex Parte Reexam Request
Aug 24, 2023RXIDS.Information Disclosure Statement Filed
Aug 24, 2023RXC/SRCertificate of Service
Aug 24, 2023RXAF/DAffidavit(s), Declaration(s) and/or Exhibit(s) Filed
Aug 24, 2023BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedDec 4, 2020

Prosecution History

DateCodeDescription
Dec 4, 2020P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Dec 4, 2020DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Mar 29, 2022
3.5-yr
Sep 29, 2025
Paid Sep 17, 2025
7.5-yr
Sep 29, 2029
11.5-yr
Sep 29, 2033
Expiry
Nov 27, 2038

Entity Status

Large Entity

Expires

Nov 27, 2038 (12.7 yr remaining)

Term Adjustment

+32 days (~0.1 yr)

Assignments

201620172018201920202021202220232024FiledSTEPHEN GRIFFINCERUS ENDOVASCULAR LIMITEDSTRYKER IRELAND TECHNOLOGY LTD.CERUS ENDOVASCULAR LIMITEDSecurity InterestMIDCAP FINANCIAL TRUSTRelease
AssignmentReel/Frame: 047346/0255Recorded: Oct 26, 2018

From

STEPHEN GRIFFINInventor
Apr 21, 2015

To

CERUS ENDOVASCULAR LIMITED

Security InterestReel/Frame: 062665/0626Recorded: Feb 11, 2023

From

CERUS ENDOVASCULAR LIMITED
Feb 3, 2023
CERUS ENDOVASCULAR, INC.
Feb 3, 2023

To

MIDCAP FINANCIAL TRUST

ReleaseReel/Frame: 063515/0943Recorded: May 2, 2023

From

MIDCAP FINANCIAL TRUST
May 2, 2023

To

CERUS ENDOVASCULAR, INC.

AssignmentReel/Frame: 066667/0328Recorded: Mar 6, 2024

From

CERUS ENDOVASCULAR LTD.
Feb 22, 2024

To

STRYKER IRELAND TECHNOLOGY LTD.